ãã®ããŒãžã§ãããããš
ãã®ã¬ã€ãã§ã¯ã(1) ãªãŒãžãªã°ã©ã ã§ç€ºãããé£èŽã®ã圢ããã©ãèªã¿åããã(2) åžè²©ã® Over-the-CounterïŒOTCïŒè£èŽåšã劥åœãªåºçºç¹ã«ãªãå ŽåãšããŸãå°éå®¶ã«çžè«ããæ¹ãããå Žåã(3) åã«ãé³ã倧ãããããã®ã§ã¯ãªããããªãèªèº«ã®è³ã«å¯ŸããŠå®å šãã€å¹æçã«è£èŽåšãèšå®ãããŠãããã確èªããããã«ãèŽèŠå°éè·ãçšããæ€èšŒæ¹æ³ã«ã€ããŠèª¬æããŸãã1
æé³é£èŽïŒå è³ã®é£èŽïŒã®ããå€ãã®æäººã«ãšã£ãŠãè£èŽåšã¯äžè¬çãªæåã®æ²»çéžæè¢ã§ãããã ãããé©åãªã次ã®äžæ©ã¯ã(a) å®å šæ§ïŒç·æ¥æ§ã®ããåé¡ãèŠéããŠããªããïŒã(b) ããªãã®èŽåãããã£ãŒã«ã(c) ããªãã®ç®æšãšæºåç¶æ³ã«ãã£ãŠæ±ºãŸããŸãããããŠãããã¯æéãšãšãã«å€ããããšããããŸãã12
ãæºåãã§ããŠããããã«ã€ããŠã®çãå®å¿ææ
èŽèŠåŠçã«ã¯ãšãŠãé©ããåè£ã§ãã£ãŠããè¿·ããäžå®ãå§åãããæ°æã¡ããããã¯ä»ã¯ãŸã æºåãã§ããŠããªããšæããããšããããŸããããã¯æ®éã®ããšã§ã倱æã§ã¯ãããŸãããèããã®å°é£ã«æ°ã¥ããŠããè£èŽæè¡ã詊ããŸã§ã«äœå¹Žãããã人ã¯å°ãªããããŸããããã®çç±ãšããŠãã»ãã®å¥åº·äžã®åªå äºé ãè²»çšãã¹ãã£ã°ãããŸãã¯å¹æãžã®äžç¢ºå®ãããããããŸãã3
ã¹ããã1ïŒãŸãå®å šã確èªããïŒOTCãèªå·±èª¿æŽãå§ããåã«ïŒ
FDAã®OTCè£èŽåšã«ããŽãªãŒïŒ2022幎ã«åµèšïŒã¯ã18æ³ä»¥äžã®æäººã§ãèªåã§è»œåºŠããäžç床ã®é£èŽã ãšæããŠãã人ããæ€æ»ãåŠæ¹ãå°éå®¶ã«ãããã£ããã£ã³ã°ãªãã§è£èŽåšãè³Œå ¥ã§ããããã«ãããã®ã§ãã24 ãã ãFDAã¯ãç¹å®ã®èŠåãµã€ã³ãããå Žåã«ã¯ããŸãå»çæ©é¢ã§è©äŸ¡ãåããããšãå§ããŠããŸããçç¶ã«ãã£ãŠã¯ãæ²»çå¯èœãŸãã¯ç·æ¥æ§ã®ããç¶æ ã瀺ããŠããããšãããããã§ãã2
次ã®èŠåãµã€ã³ãããå Žåã¯ãOTCããå§ããªãã§ãã ãã
次ã®ãããªçç¶ãããå Žåã¯ããŸãæ©ãã«å»çæ©é¢ãŸãã¯èŽèŠã±ã¢ã®è©äŸ¡ãåããããšãæ€èšããŠãã ããã2
- çªç¶ã®ããŸãã¯æ¥éã«æªåããé£èŽïŒæ°æéããæ°æ¥ä»¥å ïŒ
- çªç¶ã®è³é³ŽãããŸãã¯çè³ã®èããã®å€å
- çè³ã ãèããèãããæªãïŒå·Šå³å·®ã®ããèŽåïŒ
- è³ã®çã¿ãè³ã ããåºè¡
- ããŸãã»å転æ§ããŸããç¹ã«æ°ããèµ·ãã£ãå Žåãéãå Žå
- èŠãç®ã§ãããè³ã®å€åœ¢ããŸãã¯è³ã®æè¡æŽ
çªç¶ã®é£èŽãçåŽã ãã®æ¥ãªèããã®å€åãããå Žåã¯ãåŸ ããªãã§ãã ãããæéãšã®åè² ã«ãªãããšããããŸãã å®å šã¬ã€ãã¯ãã¡ãïŒç·æ¥æïŒèŽåã»è³é³Žãã»ãã©ã³ã¹ã®å®å šã¬ã€ãã
èŽåæ€æ»ãçè§£ãã
ãªãŒãžãªã°ã©ã ã¯ãããŸããŸãªé«ãã®é³ãã©ããããå°ãããŠãèãåãããã瀺ãã°ã©ãã§ããå®ç掻ã§ã®æå³ãçè§£ããã«ã¯ã次ã®2ã€ã®èãæ¹ãéèŠã§ãã
- çšåºŠïŒã©ãããã倧ãããã°èããããïŒ: é³ãã©ãããã倧ãããªããªããšèãããªãã®ãã
- æ§æïŒåœ¢ïŒ: ã©ã®é³åã圱é¿ãåããŠããã®ãã
ãåŸæåãïŒé«é³åïŒãã¿ãŒã³
幎霢å€åãéšé³ã®åœ±é¿ã«ããå è³ã®å€åã§ããã¿ããããã¿ãŒã³ã®äžã€ããäœãé³ã¯æ¯èŒçããèãããé«ãé³ãèããã«ãããåŸæåãã®é£èŽã§ããããã«ããã人ã®è©±ã声ã¯èãããŠããŠããsãfãthãk ãªã©ãèšèãã¯ã£ãããããé«é³ã®æããããèãéãããã¿ããªãã¢ãŽã¢ãŽè©±ããŠãããããã«æããããšããããŸãã15
ãé³éãäžãããããšãšãã¯ã£ããèããããããšã¯åãã§ã¯ãããŸãã
é«é³ã®èšèªæããããäž»ã«èãéããŠããå Žåãå šäœã®é³éãäžãããšäœé³éšåã ããããããæããããé«é³ã®æçãã¯ååã«æ¹åããªãããšããããŸãããããã£ããã£ã³ã°ã¯ãåãªã倧é³éã§ã¯ãªããèããããããšå¿«é©ãã®äž¡æ¹ãç®æããŸãã1
è£èŽåšã«ã§ããããšã»ã§ããªãããš
è£èŽåšã¯èšèã®é³ã«ã¢ã¯ã»ã¹ããããããäŒè©±ã®è² æ ãæžããããšãã§ããŸãããå·ãã å è³ããæ£åžžãªç¶æ ã«æ»ãããã®ã§ã¯ãããŸãããèæ¯éé³ã®äžã§ã®èãåãã¯äŸç¶ãšããŠé£ããããšããããŸãããã¯ãããžãŒã¯å©ãã«ãªããŸãããçŸå®ã®é³ç°å¢ãã®ãã®ãæ¶ããŠãããããã§ã¯ãããŸããã1
æ ¹æ ã«åºã¥ã广ïŒè»œåºŠããäžç床ã®é£èŽïŒ
å€§èŠæš¡ãªç³»çµ±çã¬ãã¥ãŒïŒCochraneïŒã§ã¯ã軜床ããäžç床ã®é£èŽã®æäººã«ãããŠãè£èŽåšã¯è£èŽåšã䜿ããªãå Žåãšæ¯ã¹ãŠãèŽããã«é¢é£ããçæŽ»ã®è³ªãšèãåãèœåãæ¹åããããšã瀺ãããŠããŸãã6
èããããšããããããããªãæ©èœïŒåšæ³¢æ°å§çž®ã»åšæ³¢æ°ç§»è¡
äžéšã®ææ°è£èŽåšã«ã¯ãåšæ³¢æ°äœäžåŠçïŒfrequency loweringãfrequency compression ã frequency transposition ãšãåŒã°ããŸãïŒãæèŒãããŠããŸããããã¯ãéåžžã«é«ãåšæ³¢æ°ã®äžéšã®æ å ±ããããäœãåšæ³¢æ°åž¯ã«ç§»ããŠèããããããããã®ã§ãã æšæºçãªå¢å¹ ã§ã¯é«é³åã®èãããååã«åŸã«ããå Žåã«ãäžéšã®æäººã«ã¯åœ¹ç«ã€ããšããããŸãããããããã¹ãŠã®äººã«æå¹ãšããããã§ã¯ãªããé³è³ªãèšèªã®æããããå€ãã£ãŠããŸãããšããããŸããæ éãªãã£ããã£ã³ã°ãšãã©ããŒã¢ãããéèŠã§ãã7
OTCãšåŠæ¹è£èŽåšïŒå®å šãªåºçºç¹ãéžã¶
OTCè£èŽåšã¯å©çšãããããåºããŸããã察å¿ã§ããããŒãºã®ç¯å²ã¯æ¯èŒçéãããŠããŸããåŠæ¹è£èŽåšïŒèŽèŠå°éè·ãé©åããããã®ïŒã¯ãããè€éãªèŽåãããã£ãŒã«ãå»åŠçã»å€è³éã®äºæ ãç¶ç¶çãªæ¯æŽãå¿ èŠãªå Žåã«ãããæè»ã§ãã26
| é ç® | OTCè£èŽåš | åŠæ¹è£èŽåšïŒå°éå®¶ã«ããé©åïŒ |
|---|---|---|
| æ³å®ããã䜿çšè | 18æ³ä»¥äžã§ãèªèŠçã«è»œåºŠããäžç床ã®é£èŽãããæäººïŒæ€æ»ãåŠæ¹ç®ã¯äžèŠïŒã24 | å šå¹Žéœ¢ã軜床ããé床ã»é«åºŠé£èŽãŸã§ãããåºãç¯å²ã®è³ã®ç¶æ ã»èŽåãããã£ãŒã«ã»ããŒãºã«å¯Ÿå¿ã |
| å§ãæ¹ | èªåã§èšå®ããããšãå€ãïŒå€ãã¯ã¢ããªäœ¿çšïŒãããŸã䜿ãã«ã¯ããã©ãã«å¯Ÿå¿ã調æŽã«ããçšåºŠã®æ £ããå¿ èŠãªããšããããŸãã2 | å°éçè©äŸ¡ãã«ãŠã³ã»ãªã³ã°ãèŽèŠåŠçç®æšã«åºã¥ãã調æŽã埮調æŽã®ããã®å蚺ããã |
| è³ã®åœ¢ãšå¿«é©ã | äžè¬çã«æšæºçãªã€ã€ãŒãããã䜿çšãç¹æ®ãªå€è³éãè£ çšæã®äžå¿«æãããŠãªã³ã°å¯Ÿçã®éžæè¢ã¯å°ãªãã§ãã | ã¬ã·ãŒããŒåœ¢ç¶ãã€ã€ã¢ãŒã«ãããã³ããªã©éžæè¢ãå€ããå¿«é©ãã»ããŠãªã³ã°ã»å»åŠçãªè³ã®é æ ®ã«ã察å¿ããããã§ãã |
| åããŠããã±ãŒã¹ | å·Šå³å·®ãå°ãªããå®å®ãã軜床ããäžç床ã®èããã«ããã§ãèŠåãµã€ã³ãå°ãªããçŸå®çãªæåŸ ãããå Žåã | å·Šå³å·®ã®ããèŽåãããéãé£èŽãè€éãªèãåãå Žé¢ãè³é³Žã察å¿ãå¿ èŠãªå Žåãæå ã®äœ¿ãã«ãããèŠåã®åé¡ãããå ŽåããŸãã¯å°éå®¶ã®äŒŽèµ°ãæãå Žåã |
| å®å šç¢ºèª | èŠåãµã€ã³ãèªåã§ç¢ºèªããå¿ èŠããããŸããFDAã¯ç¹å®ã®çç¶ã«ã€ããŠå»çè©äŸ¡ãæšå¥šããŠããŸãã2 | å°éè·ãèŠåãµã€ã³ã確èªããå¿ èŠã«å¿ããŠè¿œå æ€æ»ãè³éŒ»åœåç§ãšã®é£æºãã§ããŸãã |
å®çšçãªãäžéã®éã
OTCã«èå³ã¯ããããã©è¿·ã£ãŠãããªãããŸãèŽåæ€æ»ãåããããšãèããŠã¿ãŠãã ãããæçµçã«OTCãéžã¶ãšããŠããèªåã®èŽåãããã£ãŒã«ãç¥ã£ãŠããããšã§ãããå®å šã§çŽåŸã®ãã倿ããããããªããããæ¯æŽã®å€ãéžæè¢ãå¿ èŠãããªå Žé¢ã«ãæ°ã¥ãããããªããŸãã1
èŽåæ€æ»ããæ£åžžãã§ãå°ã£ãŠããå Žå
æšæºçãªãªãŒãžãªã°ã©ã ã§ã¯èŽåéŸå€ãæ£åžžïŒãŸãã¯ã»ãŒæ£åžžïŒã§ããå®éã«ã¯å°é£ãæãã人ãããŸããç¹ã«ãéé³ã®äžã§ã®äŒè©±ããèãç¶ããããšã«ããç²ãã§ããæãããããªããŸããç ç©¶ã§ã¯ããããhidden hearing lossïŒé ãé£èŽïŒãããlistening difficultiesïŒèãåãå°é£ïŒããšåŒã¶ããšããããŸãããåå ã¯äžã€ã§ã¯ãªããéšé³ã«ããç¥çµã®å€åãèŽèŠåŠçã®èŠå ãæ³šæåãå¥åº·ç¶æ ãªã©ãè€æ°ã®èŠå ãé¢ä¿ããããšããããŸãããããå®¶åºã§èšºæã§ããåäžã®æ€æ»ã¯ãªããããéé³äžèªé³æ€æ»ãããåºãè©äŸ¡ã«ã€ããŠãèŽèŠå°éè·ã«çžè«ããããçç±ã«ãªããŸãã89
èŽåãäžè¬çã§ããè£å©æ©åšã圹ç«ã€ããšããããŸã
é¢ããè·é¢ãèæ¯éé³ã®å€ãç°å¢ã§ã¯ããªã¢ãŒããã€ã¯ã·ã¹ãã ã®ãããªè£å©èŽåæ©åšããäŒè©±ã®çè§£ã倧ããæ¹åããããšããããŸããããæäººç ç©¶ã§ã¯ããªã¢ãŒããã€ã¯ã¯é£èŽã®ããæäººã ãã§ãªããé£ããèãåãç°å¢ã«ãããŠæ£åžžãªèŽåéŸå€ãæã€æäººçŸ€ã§ãèªé³èªèãæ¹åããŸããã10
ãŸããã³ãã¥ãã±ãŒã·ã§ã³ã®å·¥å€«ãã¢ã¯ã»ã·ããªãã£ã®ããŒã«ïŒåå¹ã座åžäœçœ®ã®å·¥å€«ãéšé³ãæžããããšïŒã圹ç«ã€å¯èœæ§ããããŸããåç §ïŒé£èŽããããšãã®ã³ãã¥ãã±ãŒã·ã§ã³æŠç¥ã
æ€èšŒã®éèŠæ§ïŒå®è³æž¬å® / REMïŒ
è£èŽåšã¯éåžžãNAL-NL2 ã DSL ã®ãããªãæ€èšŒããããç®æšåŠæ¹ãã«åºã¥ããŠèª¿æŽãããŸããããããåãè£èŽåšã®èšå®ã§ããå€è³éã®åœ¢ãè£ çšç¶æ ã«ãã£ãŠãéŒèã«å±ãå®éã®é³ã®å€§ããã¯å€ãããŸããæ€èšŒãšã¯ãå°éè·ãå®éã«è³ã«å±ããŠããé³ã確èªããå®å šã«èª¿æŽããããã®æ¹æ³ã§ãã11
å®è³æž¬å®ïŒREMïŒïŒprobe-microphone measures ãšãåŒã°ããŸãïŒã§ã¯ã现ããã€ã¯ãã¥ãŒããå€è³éå ã«å ¥ããã¹ããŒã«ãŒããé³ãåºããŠæž¬å®ããŸããããã«ãããå¢å¹ ããã話ã声ãããªãã«ãšã£ãŠèãããããå¿«é©ãã©ããããŸãè£èŽåšãæ ¹æ ã«åºã¥ãç®æšã«åã£ãŠãããã©ããã確èªã§ããŸãã1112
ãšããã³ã¹ã瀺ããŠããããšïŒãããŠç€ºããŠããªãããšïŒ
系統çã¬ãã¥ãŒã§ã¯ããããŒããã¥ãŒãã«ããæ€èšŒã¯ãè£èŽåšãåŠæ¹ç®æšã«ã©ãã ãè¿ã¥ãããæ¹åããããšã瀺ãããŠããŸããæ£è ã¢ãŠãã«ã ã®æ¹åã瀺ããšããã³ã¹ããããŸãããå©çšå¯èœãªç ç©¶æ°ãç ç©¶ãã¶ã€ã³ã«ã¯ãŸã éçããããŸããããããããèšãã°ãREMã¯éåžžã«æåãªãã¹ããã©ã¯ãã£ã¹ã®éå ·ã§ãããç¹ã«å¢å¹ äžè¶³ãå¢å¹ ããããé¿ããç¹ã§åœ¹ç«ã€å¯èœæ§ãé«ãäžæ¹ãããã ãã§äœããã解決ããéæ³ã®éå ·ã§ã¯ãããŸããã11
ã©ã決ãããïŒç®æšãæ¯æŽããããŠãèªåã®ç掻ãžã®åãæ¹ã
è£èŽãã¯ãããžãŒãéžã¶ããšã¯ãèšåºçãªå€æã§ãããšåæã«å人çãªå€æã§ããããŸããèãæ¹ãšããŠåœ¹ç«ã€ã®ã¯ãã©ã®åé¡ããã©ã®å Žé¢ã§ãã©ã®çšåºŠã®æ¯æŽã§è§£æ±ºãããã®ããšããèŠç¹ã§ãã
æºåç¶æ³ãå°éãããã§ãã¯ãªã¹ã
- æåªå ã®å Žé¢ïŒ ã©ããªå Žé¢ã§æãæ¹åãããã§ããïŒä»äºã®äŒè°ãã¬ã¹ãã©ã³ãå®¶æãšã®äŒè©±ãé»è©±/ãã¬ããé転ãªã©ïŒïŒ
- æ¯æŽã®å¥œã¿ïŒ å°éå®¶ã®äŒŽèµ°ãã»ããã§ããããããšãèªåã§èª¿æŽãããã©ãã«å¯Ÿå¿ãããã§ããïŒ
- å¥åº·ç¶æ ïŒ ç¡ç ãããŸããã¡ã³ã¿ã«ãã«ã¹ãèªç¥ãæå ã®äœ¿ãããããèŠåãªã©ãä»ã®çŸå®çãªéžæã«åœ±é¿ããèŠå ã¯ãããŸããïŒ
- 詊çšèšç»ïŒ 詊çšã»è¿åããªã·ãŒã¯ã©ããªã£ãŠããŸãããã©ã®ãããªãã©ããŒã¢ãããåããããŸããïŒ
ãéããããåã«èããŠãããã質å
- ãç§ã®çç¶ã ãšãOTCã詊ãåã«è³éŒ»åœåç§ãèŽèŠå°éè·ãå蚺ããæ¹ãããã§ããããïŒã2
- ãéããªå Žæãšéšãããå Žæã§ãããããã©ã®çšåºŠã®å¹æãæåŸ ã§ããŸããïŒã1
- ãå®è³æž¬å®ïŒãããŒããã€ã¯æž¬å®ïŒã§ãã£ããã£ã³ã°ãæ€èšŒããŠããããŸããïŒã11
- ã詊çšã»è¿åæéã¯ã©ããããã§ãã©ããªãã©ããŒã¢ãããå«ãŸããŸããïŒã1
ãããã質å
èŠç¹
è£èŽãã¯ãããžãŒã¯ãå®å šã«éžã°ããããªãã®å¿ èŠã«åãããŠèª¿æŽããããšãã«æã广ãçºæ®ããŸããOTCè£èŽåšã¯ã軜床ããäžç床ã§å®å®ããèããã«ããã®ããäžéšã®æäººã«ã¯åŠ¥åœãªåºçºç¹ã«ãªãåŸãŸãããèŠåãµã€ã³ãè€éãªãã¿ãŒã³ãããå Žåã¯ããŸãå°éçè©äŸ¡ãå¿ èŠã§ãã2
åŠæ¹è£èŽåšãéžã¶å Žåã¯ãã¯ãªããã¯ã§å®è³æž¬å®ïŒãããŒããã€ã¯æž¬å®ïŒã«ãããã£ããã£ã³ã°æ€èšŒãè¡ã£ãŠãããããŸãå¿«é©ããšæçãã埮調æŽããããã®ãã©ããŒã¢ãããèšç»ãããŠãããã確èªããŠãã ããã11
ç®æšã¯ããã£ãšå€§ããé³ãã§ã¯ãããŸãããããæçãªã³ãã¥ãã±ãŒã·ã§ã³ãããå°ãªãè² æ ããããŠããªãã®å®ç掻ã«åã£ãæ¯æŽã§ãã
次ã®ã¹ãããïŒèŽåè©äŸ¡ãåãã
è£èŽåšãã»ãã®éžæè¢ã«ã€ããŠå°éå®¶ãšäžç·ã«æ€èšããŠã¿ãŸããããå æ¬çãªèŽåè©äŸ¡ã«ãã£ãŠãäœãèµ·ããŠããã®ãããããŠã©ã®éžæè¢ãããªãã®ç®æšã«æãåã£ãŠããã®ããæç¢ºã«ãªããŸãã
åèæç®äžèŠ§ïŒæ ¹æ ãšèŠå¶ïŒ
åèæç®ã¯ãèšåºçã«éèŠãªèšè¿°ïŒå®å šæ§/ããªã¢ãŒãžãOTCã®å¯Ÿè±¡ç¯å²ãå©ç¹/éçãæ€èšŒïŒãè£ã¥ããããã«æ²èŒããŠããŸãããã®ããŒãžã¯æè²ç®çã§ãããåå¥ã®å»çå©èšã®ä»£ããã«ã¯ãªããŸããã
- National Institute on Deafness and Other Communication Disorders (NIDCD). Hearing Aids (fact sheet). Updated/posted 2023. NIH/NIH-NIDCD. https://www.nidcd.nih.gov/health/hearing-aids
- U.S. Food & Drug Administration (FDA). OTC Hearing Aids: What You Should Know. (Consumer guidance on eligibility and warning signs). Accessed 2026. https://www.fda.gov/medical-devices/hearing-aids/otc-hearing-aids-what-you-should-know
- Knudsen LV, Ãberg M, Nielsen C, Naylor G, Kramer SE. Factors influencing help seeking, hearing aid uptake, hearing aid use and satisfaction with hearing aids: a review of the literature. Trends in Amplification. 2010. https://journals.sagepub.com/doi/10.1177/1084713810385712
- Electronic Code of Federal Regulations (eCFR). 21 CFR § 800.30 â Over-the-counter (OTC) hearing aid (definition and scope). Accessed 2026. https://www.ecfr.gov/current/title-21/chapter-I/subchapter-H/part-800/subpart-B/section-800.30
- AAO-HNSF. Clinical Practice Guideline: Age-Related Hearing Loss. OtolaryngologyâHead and Neck Surgery. 2024 (epdf). https://aao-hnsfjournals.onlinelibrary.wiley.com/doi/epdf/10.1002/ohn.803
- Ferguson MA, Kitterick PT, Chong LY, Edmondson-Jones M, Barker F, Hoare DJ. Hearing aids for mild to moderate hearing loss in adults. Cochrane Database of Systematic Reviews. 2017;CD012023. Cochrane summary: https://www.cochrane.org/evidence/CD012023_hearing-aids-mild-moderate-hearing-loss-adults (PDF mirror): https://nottingham-repository.worktribe.com/preview/884346/Ferguson_et_al-2017-.pdf
- Simpson A, Bond A, Loeliger M, Clarke S. Speech intelligibility benefits of frequency-lowering algorithms in adult hearing aid users: a systematic review and meta-analysis. Journal of Audiology & Otology. 2024. https://www.ejao.org/journal/view.php?doi=10.7874/jao.2024.00122
- Liberman MC, Epstein MJ, Cleveland SS, Wang H, Maison SF. Toward a Differential Diagnosis of Hidden Hearing Loss in Humans. PLOS ONE. 2016. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0162726
- Munro KJ, Dillon H, Almufarrij I. Does Probe-Tube Verification of Real-Ear Hearing Aid Amplification Characteristics Improve Outcomes in Adults? A Systematic Review and Meta-Analysis. Trends in Hearing. 2021. https://journals.sagepub.com/doi/pdf/10.1177/2331216521999563
- Picou EM, Thibodeau LM, et al. Evaluating benefits of remote microphone technology for adults with hearing loss and adults with normal hearing. International Journal of Audiology. 2024. https://www.tandfonline.com/doi/pdf/10.1080/14992027.2024.2354500
- American Academy of Audiology. Online Feature: Real-Ear Verification for the New Professional (practice-focused overview referencing evidence-based prescriptive targets). Accessed 2026. https://www.audiology.org/news-and-publications/audiology-today/articles/online-feature-real-ear-verification-for-the-new-professional/
- American Academy of Audiology. A Systematic Review of Health-Related Quality of Life and Hearing Aids: Final Report of the AAA Task Force. 2007 (Practice guideline resource page). https://www.audiology.org/practice-guideline/a-systematic-review-of-health-related-quality-of-life-and-hearing-aids-final-report-of-the-american-academy-of-audiology-task-force-on-the-health-related-quality-of-life-benefits-of-amplification-in/